Treating generalised anxiety disorder
- Alison Tonks (atonks@bmj.com), freelance medical editor
- BMJ Unified, London WC1H 9JR
- Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
- BMJ Unified, London WC1H 9JR
Description Generalised anxiety disorder is a chronic, disabling mental illness affecting 1-2% of adults.1 It is characterised by worry and anxiety that are hard to control and that interfere with daily functioning. Although common and treatable, it remains underdiagnosed and undertreated.2 Only half of people with the disorder consult a doctor for it. Those who do are rarely offered the most effective treatment—cognitive therapy. Most patients are seen and treated by primary care doctors, who may be unfamiliar with the condition. About 8% of patients consulting primary care professionals have generalised anxiety disorder.3 Treatment involves cognitive therapy or medication. There are large gaps in the evidence on treatments, such as on their long term effects or on the value of combining cognitive therapy with medication.
Research Several factors complicate research into treatment of generalised anxiety disorder:
Drug trials have high dropout rates, partly because of side effects4
The disorder has a relapsing and remitting course; improvements are not always due to treatment
The placebo effect is powerful—trials have to be large to show a treatment effect5
Most treatments take several weeks or even months to work2
The definition of generalised anxiety disorder has changed four times since 1980.6
Prognosis Complete recovery is rare. Explain to your patients that you are aiming for remission rather than cure. A reasonable goal is to reduce symptoms by about 50% and improve quality of life.7 Patients shouldn't expect any benefit until eight to 12 weeks after starting treatment.2
Treatment
These articles, and the patients' version, will help you and your patients discuss treatment options together and choose treatments that are supported by evidence from randomised controlled trials. Clear, concise information is important for people with generalised anxiety disorder, who may have difficulty concentrating or making …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: A prescription for improving antibiotic prescribing in primary care
Published 15 February 2012
Re: Migrant healthcare: public health versus politics
Published 15 February 2012
Re: Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?
Published 15 February 2012
Re: Scientists are to investigate “three parent IVF” for preventing mitochondrial diseases
Published 15 February 2012
Re: A commitment to protect health and save lives
Published 15 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012